Pharmaceutical

Elsie and GSK link to accelerate oligonucleotide discovery platform

Elsie has signed a research collaboration agreement with GSK to accelerate the development of its oligonucleotide discovery platform.

Jul 11, 2023 - 20:00
Elsie and GSK link to accelerate oligonucleotide discovery platform
Elsie has signed a research collaboration agreement with GSK to accelerate the development of its oligonucleotide discovery platform.
Read the original article

Tags:

Previous Article

BeiGene to acquire DualityBio’s ADC therapy for solid tumours

Next Article

MHRA approves GSK’s RSV vaccine for older adults in the UK

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Tanden, Becerra, Califf make time for a meeting with tobacco lobbyists on the menthol ban

Tanden, Becerra, Califf make time for a meeting with to...

Nov 29, 2023

Moderna cuts five programmes to save $1.1bn in R&D costs

Moderna cuts five programmes to save $1.1bn in R&D costs

Sep 14, 2024

STAT+: Beleaguered drug manufacturer Emergent cuts jobs, executive role in business shake-up

STAT+: Beleaguered drug manufacturer Emergent cuts jobs...

Aug 9, 2023